Growth Metrics

UL Solutions (ULS) Other Accumulated Expenses (2023 - 2026)

Quarterly results put Other Accumulated Expenses at $92.0 million for Q1 2026, up 61.4% from a year ago — trailing twelve months through Mar 2026 was $92.0 million (up 61.4% YoY), and the annual figure for FY2025 was $79.0 million, up 46.3%.

UL Solutions has reported Other Accumulated Expenses over the past 4 years, most recently at $92.0 million for Q1 2026.

  • Other Accumulated Expenses reached $92.0 million in Q1 2026 per ULS's latest filing, up from $79.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $92.0 million in Q1 2026 and bottomed at $47.0 million in Q3 2025.
  • Median Other Accumulated Expenses over the past 4 years was $57.5 million (2023), compared with a mean of $65.5 million.
  • The largest annual shift saw Other Accumulated Expenses crashed 41.46% in 2025 before it skyrocketed 61.4% in 2026.
  • Over 4 years, Other Accumulated Expenses stood at $58.0 million in 2023, then fell by 6.9% to $54.0 million in 2024, then soared by 46.3% to $79.0 million in 2025, then rose by 16.46% to $92.0 million in 2026.
  • Business Quant data shows Other Accumulated Expenses for ULS at $92.0 million in Q1 2026, $79.0 million in Q4 2025, and $47.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Relx 81.40 Bn 81.16 Bn -
2 Rentokil Initial 79.56 Bn 78.10 Bn -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 92.00 Mn
Dec 31, 2025 79.00 Mn
Sep 30, 2025 47.00 Mn
Jun 30, 2025 48.00 Mn
Mar 31, 2025 57.00 Mn
Dec 31, 2024 54.00 Mn
Sep 30, 2024 57.00 Mn
Jun 30, 2024 82.00 Mn
Mar 31, 2024 81.00 Mn
Dec 31, 2023 58.00 Mn